Ninth ChinaBio Partnering Forum Celebrates China Life Science "Sea Change"
Published: Jul 05, 2017
In late May, ChinaBio® Group and EBD Group convened the ninth iteration of the ChinaBio® Partnering Forum. This year's event took place against a very positive industry backdrop of rapidly accelerating change -- 34 new funds focused on China life-science funds raised over $15 billion last year and $5.4 billion was invested, three times the previous year's $1.8 billion. In addition, China has taken numerous steps to bring its drug development regulations in line with global practices, a "sea change" that will speed up approvals of novel drugs. The ninth CBPF, which took place in Zhuhai, China, hosted 858 attendees representing 460 companies from 30 countries. It featured over 50 company presentations, and the attendees scheduled a record-breaking 1,682 meetings from over 6,800 requests.